Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mutant p53 Gain-of-Function: Role in Cancer Development, Progression, and Therapeutic Approaches
Eduardo Alvarado-Ortiz, Karen Griselda de la Cruz-López, Jared Becerril-Rico, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 8
Open Access | Times Cited: 124

Showing 1-25 of 124 citing articles:

Drugging p53 in cancer: one protein, many targets
Ori Hassin, Moshe Oren
Nature Reviews Drug Discovery (2022) Vol. 22, Iss. 2, pp. 127-144
Open Access | Times Cited: 406
Should mutant TP53 be targeted for cancer therapy?
Zilu Wang, Andreas Strasser, Gemma L. Kelly
Cell Death and Differentiation (2022) Vol. 29, Iss. 5, pp. 911-920
Open Access | Times Cited: 89
Targeting apoptotic pathways for cancer therapy
Xiaobing Tian, Praveen R. Srinivasan, Vida Tajiknia, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 14
Open Access | Times Cited: 22
The impact of ribosome biogenesis in cancer: from proliferation to metastasis
Sseu-Pei Hwang, Catherine Denicourt
NAR Cancer (2024) Vol. 6, Iss. 2
Open Access | Times Cited: 19
Disorders of cancer metabolism: The therapeutic potential of cannabinoids
Dingya Sun, Xin Li, Shengdan Nie, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 157, pp. 113993-113993
Open Access | Times Cited: 66
Gain-of-function p53R172H mutation drives accumulation of neutrophils in pancreatic tumors, promoting resistance to immunotherapy
Despina Siolas, Emily Vucic, Emma Kurz, et al.
Cell Reports (2021) Vol. 36, Iss. 8, pp. 109578-109578
Open Access | Times Cited: 61
p53 Modulation of Autophagy Signaling in Cancer Therapies: Perspectives Mechanism and Therapeutic Targets
Md. Ataur Rahman, Moon Nyeo Park, MD. Hasanur Rahman, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 57
Key biological mechanisms involved in high-LET radiation therapies with a focus on DNA damage and repair
Zacharenia Nikitaki, Anastasia Velalopoulou, Vassiliki Zanni, et al.
Expert Reviews in Molecular Medicine (2022) Vol. 24
Open Access | Times Cited: 41
The complex network of transcription factors, immune checkpoint inhibitors and stemness features in colorectal cancer: A recent update
Maysaloun Merhi, Fareed Ahmad, Nassiba Taib, et al.
Seminars in Cancer Biology (2023) Vol. 89, pp. 1-17
Open Access | Times Cited: 22
TP53 Mutation-Mediated Immune Evasion in Cancer: Mechanisms and Therapeutic Implications
Chuqi Wang, Jordan Yong Ming Tan, N. L. Chitkara, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 3069-3069
Open Access | Times Cited: 13
Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer
Kyu Sic You, Yong Weon Yi, Jeonghee Cho, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 6, pp. 589-589
Open Access | Times Cited: 46
Gain of Function (GOF) Mutant p53 in Cancer—Current Therapeutic Approaches
Katarzyna Roszkowska, Aleksandra Piecuch, Maria Sady, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13287-13287
Open Access | Times Cited: 32
Small-molecule correctors and stabilizers to target p53
Maryam M.J. Fallatah, Fiona V. Law, Warren Chow, et al.
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 5, pp. 274-289
Open Access | Times Cited: 20
Relationship between p53 status and the bioeffect of ionizing radiation (Review)
Xiaohan Kong, Dehai Yu, Zhaoyi Wang, et al.
Oncology Letters (2021) Vol. 22, Iss. 3
Open Access | Times Cited: 37
Opposing Roles of Wild-type and Mutant p53 in the Process of Epithelial to Mesenchymal Transition
Oleg Semenov, Alexandra Daks, Olga Fedorova, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 27
GOF Mutant p53 in Cancers: A Therapeutic Challenge
Lobsang Dolma, Patricia Müller
Cancers (2022) Vol. 14, Iss. 20, pp. 5091-5091
Open Access | Times Cited: 22
Loss of RanGAP1 drives chromosome instability and rapid tumorigenesis of osteosarcoma
Yan Gong, Shitian Zou, Daizhao Deng, et al.
Developmental Cell (2023) Vol. 58, Iss. 3, pp. 192-210.e11
Open Access | Times Cited: 15
Targeting mutant p53 stabilization for cancer therapy
Jiajian Wang, Wenjun Liu, Lanqing Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 14
Enhancing Therapeutic Approaches in Glioblastoma with Pro-Oxidant Treatments and Synergistic Combinations: In Vitro Experience of Doxorubicin and Photodynamic Therapy
Bruno Agustín Cesca, Matías Daniel Caverzán, María Julia Lamberti, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7525-7525
Open Access | Times Cited: 5
TP53 mutations in cancer: Molecular features and therapeutic opportunities (Review)
Maria Lina Tornesello
International Journal of Molecular Medicine (2024) Vol. 55, Iss. 1
Open Access | Times Cited: 5
Indonesian Newcastle Disease Virus Field Isolate Reduces c-Jun Expression in Rat Mammary Cancer Models
Fransiska Gratia Sonita Marson, Palagan Senopati Sewoyo, I Nyoman Mantik Astawa, et al.
Media Kedokteran Hewan (2025) Vol. 36, Iss. 1, pp. 13-20
Open Access
Effect of cytotoxic CD8+ T-cells secretory proteins on hypoxic pancreatic cancer cells
Eiman Abdo, Mohammad A. Ismail, Sabal Al Hadidi, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0311615-e0311615
Open Access
Pestones A and B from a Fungus Pestalotiopsis sp. Bound to Mutant p53 and Changed Its Conformation
Yusaku Sadahiro, Masakazu Okubo, Yuki Hitora, et al.
Journal of Natural Products (2025)
Closed Access
Transplantation outcomes of TP53-mutant AML and MDS: a single transplantation center experience of 63 patients
Yasutaka Masuda, Daichi Sadato, Takashi Toya, et al.
International Journal of Hematology (2025)
Closed Access
Suppression of stress granule formation is a vulnerability imposed by mutant p53
Elizabeth Thoenen, Atul Ranjan, Alejandro Parrales, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top